Association of Maternal History of Allergic Features with Preterm Pregnancy Outcomes in the Japan Environment and Children's Study.


Journal

International archives of allergy and immunology
ISSN: 1423-0097
Titre abrégé: Int Arch Allergy Immunol
Pays: Switzerland
ID NLM: 9211652

Informations de publication

Date de publication:
2021
Historique:
received: 30 07 2020
accepted: 14 12 2020
pubmed: 19 2 2021
medline: 21 9 2021
entrez: 18 2 2021
Statut: ppublish

Résumé

Previous studies have reported that maternal asthma increases the risk of preterm birth. We hypothesized that inflammatory reactions caused by allergic diseases might affect the uterine environment and, subsequently, perinatal outcomes. The objective of this study was to examine the associations between allergic features among mothers and preterm pregnancy outcomes in a nationwide birth cohort. We analyzed data from pregnant women obtained from the Japanese Environment and Children's Study (JECS), a nationwide general birth cohort study. We used binomial and multinomial logistic regression models to examine the associations between maternal allergic features and preterm birth, threatened preterm labor (TPL), and preterm premature rupture of the membrane (PPROM). A total of 97,683 pregnant women were included. Prevalence of preterm birth, TPL, and PPROM was 4.7, 19.6, and 1.2%, respectively. Maternal history of allergic diseases (asthma, allergic rhinitis, allergic conjunctivitis, food allergy, drug allergy, and contact dermatitis) increased the risk of TPL(adjusted odds ratio [aOR] = 1.11 [95% CI: 1.06-1.17], aOR = 1.12 [1.08-1.16], aOR = 1.10 [1.04-1.16], aOR = 1.17 [1.09-1.26], aOR = 1.35 [1.23-1.48], and aOR = 1.34 [1.20-1.49], respectively). Although some maternal allergic features showed a negative association with preterm birth, the variables affecting preterm birth differed according to the gestational age of the fetus (22-33 weeks vs. 34-36 weeks). There were no significant associations between maternal allergic features and PPROM. Maternal allergic disease, except atopic dermatitis, may increase the risk of TPL. Comorbidity of maternal allergic disorders and perinatal adverse outcomes require further investigation.

Identifiants

pubmed: 33601376
pii: 000513749
doi: 10.1159/000513749
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

650-662

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Mayko Saito-Abe (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan, saito-myk@ncchd.go.jp.
Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Nagakute, Japan, saito-myk@ncchd.go.jp.

Kiwako Yamamoto-Hanada (K)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Kyongsun Pak (K)

Division of Biostatistics, Department of Data Management, Center for Clinical Research, National Center for Child Health and Development, Tokyo, Japan.

Miori Sato (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.
Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.

Makoto Irahara (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Hidetoshi Mezawa (H)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Hatoko Sasaki (H)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Minaho Nishizato (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Kazue Ishitsuka (K)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Mizuho Konishi (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Limin Yang (L)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Yukihiro Ohya (Y)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Kohta Suzuki (K)

Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH